Network-based proteomic approaches reveal the neurodegenerative, neuroprotective and pain-related mechanisms involved after retrograde axonal damage by Casas Louzao, Caty et al.
Network-based proteomic approaches
reveal the neurodegenerative,
neuroprotective and pain-related
mechanisms involved after retrograde
axonal damage
Caty Casas1, Laura Isus2, Mireia Herrando-Grabulosa1, Francesco M. Mancuso4*, Eva Borra´s4,
Eduardo Sabido´4, Joaquim Fore´s5 & Patrick Aloy2,3
1Group of Neuroplasticity and Regeneration, Institut de Neurocie`ncies and Department of Cell Biology, Physiology and Immunology,
Universitat Auto`noma de Barcelona, and Centro de Investigacio´n Biome´dica en Red sobre Enfermedades Neurodegenerativas
(CIBERNED), 08193 Bellaterra, Barcelona, Spain, 2Joint IRB-BSC-CRG Program in Computational Biology. Institute for Research in
Biomedicine (IRB Barcelona), 08028 Barcelona, Catalonia, Spain, 3Institucio´ Catalana de Recerca i Estudis Avançats (ICREA),
08010 Barcelona, Catalonia, Spain, 4Proteomic Unit, Centre for Genomic Regulation (CRG) and UPF, Dr. Aiguader 88, 08003
Barcelona, Spain, 5Hand and Peripheral Nerve Unit, Hospital Clı´nic i Provincial, Universitat de Barcelona, Barcelona, Spain.
Neurodegenerative processes are preceded by neuronal dysfunction and synaptic disconnection.
Disconnection between spinal motoneuron (MN) soma and synaptic target leads either to a retrograde
degenerative process or to a regenerative reaction, depending injury proximity among other factors.
Distinguished key events associated with one or other processes may give some clues towards new
therapeutical approaches based on boosting endogenous neuroprotective mechanisms. Root mechanical
traction leads to retrograde MN degeneration, but share common initial molecular mechanisms with a
regenerative process triggered by distal axotomy and suture. By 7 days post-injury, key molecular events
starts to diverge and sign apart each destiny. We used comparative unbiased proteomics to define these
signatures, coupled to a novel network-based analysis to get biological meaning. The procedure implicated
the previous generation of combined topological information frommanual curated 19 associated biological
processes to be contrasted with the proteomic list using gene enrichment analysis tools. The novel and
unexpected results suggested that motoneurodegeneration is better explained mainly by the concomitant
triggering of anoikis, anti-apoptotic and neuropathic-pain related programs. In contrast, the endogenous
neuroprotective mechanisms engaged after distal axotomy included specifically rather anti-anoikis and
selective autophagy. Validated protein-nodes and processes are highlighted across discussion.
A
xonal injuries often result in a permanent loss of vital neuronal functions, which occur through a
retrograde process of neuronal atrophy and death. This phenomenon is observed in apparently divergent
cases such as neurodegenerative diseases, where the axon of an unhealthy neuron degenerates over
months before succumb, or after acute peripheral nerve diseases or trauma. In particular, traumatic axotomy
ormechanical traction (avulsion) of the nerves is caused by traffic accidents or work and sportive activities, or as a
consequence of obstetric complications, which cause severe irreversible dysfunction and/or monoplegia1. These
lesions are complex to reconstitute surgically due to the absence of a proximal nerve stump by retraction of it ends.
When successful reimplantation is performed rerouting other nerves minor recovery of function is obtained2,3.
Root avulsion also commonly results in early deafferentation pain which can develop into central sensitization
and severe neuropathic pain. This painful state is usually refractory to pharmacotherapy. Spinal cord dorsal horn
central sensitization is linked to neuronal hyperexcitability and the increase of glial immunoreactivity4. How
acute injury transforms to chronic pain remains a long-standing unresolved question, with important medical
implications. Experimentally we can reproduce traumatic root avulsion leading to a time-dependent course of
around 80% of motoneuron (MN) loss along the first month after injury5. Repeatedly, it has been reported that
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retrograde degeneration depends on several factors such as age,
region of injury (cervical vs lumbar), species of animals examined
(rat vs mouse) and the distance of the axon injury to the soma. The
effects are more severe if the axotomy occurs closer to the soma such
as after root avulsion (RAmodel). In contrast, a distal nerve axotomy
plus suture result in MN survival and axonal regeneration (distal
axotomy (DA) model,)6.Despite recent advances, the molecular
mechanisms leading to retrograde MN degeneration are far from
clear. Adult MNs do not seem to die by apoptosis as neonatal neu-
rons do after root avulsion. However, this is still a matter of contro-
versy and other authors postulate they may die by necrosis7–11 In the
last years, in order to shed light into this neurodegenerative process,
we have collected growing evidences showing that RA and DA trig-
gered common initial molecular events that start to diverge from 7
days post injury (dpo). These differing events are characterized by
the unbalanced response of pro-survival mechanisms such as the
response to unfolded proteins or autophagy11. However the ques-
tions of how MNs die and by which mechanisms remain unclear.
In addition, no clue has been retrieved about the endogenous mech-
anism triggered by distal axotomized MNs to allow them survive. In
thismanuscript, we present a network-based proteome-wide analysis
designed to unveil these mechanisms whose relevance for therapy in
trauma is also discussed.
Results
We initially performed a label free proteomic analysis that allows
finding out both quantitative and qualitative differences in the rat
models of RA and DA performed on the sciatic nerve. Seven days
post injury was the targeted time-point where signalling mechanism
started to diverge in both models signing for different end course
towards either regeneration or degeneration11. The LC-MS/MS ana-
lysis of the cytosolic fractions from L4–L5 spinal cord segments
resulted in the identification of a total of 1,420 proteins with at least
two peptides per protein (supplementary Table S1A). A total of 439
and 481 proteins or peptides were significantly altered due to DA or
RA respect to the control (p, 0.05) (supplementary Tables S1B and
S1C, respectively). In order to dissect out the neurodegenerative
processes from the endogenous neuroprotective programs that can
be triggered simultaneously, we compared both types on injuries
between them and we found that among 567 different proteins (sup-
plementary Table S2A), 109 were found unique to be altered only
after DAwhile 148 signed the RAprocess (supplementary Tables S2B
and S2C, respectively). We attempted for functional annotation of
these unique proteins using the DAVID annotation tool, which
allowed identifying the most significant biological functions in the
data set (FDR , 0.05). In particular for the regenerative course, the
cellular components were linked to: chaperoning containing t-com-
plex (66% of enrichment) and SNARE complex (27%) as well as to
microtubule cytoskeleton (4.3%) and neuronal projection (3.9%). In
contrast, unique proteins in the degenerative process were related to
the ribosomal (41%) and translation machinery (41%). Both models
shared in common that the most represented biological pathways
were linked to that of ribosomes (KEGG#ko03010) (16 proteins
involved out of 73). Interestingly, manual curator analysis revealed
that 15 proteins among these signatures were enzymes related to
aminoacid, fatty acid or citrate cycle metabolisms such as dihydro-
lipoamide s-succinyltransferase, fatty acid synthase, or malate dehy-
drogensase, respectively.
Although informative, Gene ontology (GO) terms and KEGG
pathways enrichment analyses were difficult to interpret from a
patho-physiological perspective since they define general molecular
processes that are common to many other disorders. Thus, we
developed a computational analysis workflow for interpreting global
protein abundance based on the generation of curated biological
networks associated to axon injuries and a posterior GSEA analysis.
An initial list of key proteins (seeds) associated to molecular pro-
cesses that could be involved in neuronal response to axon damage
was extracted by literature scrutiny, with high content on pathways
and protein complexes linked to either neuroprotection/regenera-
tion or degeneration/pain.We then built the networks related to each
of these molecular processes directly associated to axonal injury and
ran a GSEA analysis to determine whether the expression of genes
associated to the motives are significantly altered in any of the
conditions.
We found that some motives were commonly up or down regu-
lated in both models such as apoptosis and anoikis, a type of pro-
grammed cell death with some common pathways with apoptosis.
GSEA revealed that genes involved in pathways related to apoptosis
were significantly up regulated at protein level in both DA (p value:
0.009) and RA (p value: 0.04) models, in comparison with controls,
for seeds, high confidence (first and second degree) and in binary
networks (first and second degree). Regarding anoikis, while for DA
model only the last type of network was significant (p value: 0.01), for
the RA model it was significant for high confidence second degree
network (p value: 0.032) and ALL network (p value: 0.021) (Fig. 1).
Some other highly divergent events appear to be associated par-
ticularly only to one of the models. On one hand, the RA showed a
significant enrichment for anti-apoptosis and pain motives against
the seed lists but none of them was significantly enriched in DA
models. Pain motive was significantly up regulated in the RA model
for seeds (p value: 0.02), high confidence networks (first p value:
0.009 and second degree p value: 0.014) and binary networks (first
p value: 0.001 and second degree p value: 0.002). Similarly, anti-
apoptosis mechanisms were significantly up regulated for seeds (p
value: 0.038), high confidence networks (first p value: 0.025 and
second degree p value: 0.045), binary and second degree networks
(p value: 0.016) and networks containing ALL interactions (p value:
0.013) (Fig. 1). No more mechanisms were revealed when analysed
the seed list, however when considered ALL networks the RA model
was significantly enriched for anti-ageing and molecular mechan-
isms related with the rearrangement of cytoskeleton and organelles
motives (anti-ageing p value: 0.024, and rearrangement of cytoske-
leton p value: 0.028.).
On the other hand, the DA was significantly enriched for five
motives, in comparison with controls, that were not significant in
the RA. In particular, selective autophagymotive was significantly up
regulated for the seeds (p value: 0.018), high confidence one degree (p
value: 0.040) and binary one degree networks (p value: 0.038)
whereas anti-anoikis, ROS hormesis, autophagosome membrane
fusion, and nucleolar stress events were significantly down regulated
(Fig. 1).
The last condition analysed was the direct comparison between
DA against RA models. From the direct comparison of the two
models, only one motive was up regulated in the DA compared with
the RA. The anti-aging motive was significantly up regulated for the
ALL network (p value: 0.048). In the other site, five motives were
found to be down-regulated in DA models in comparison with RA,
such as regeneration, anti-oxidant mechanisms, anti-anoikis, autop-
hagosome membrane fusion events and nucleolar stress. All of them
were significant when analysing high confidence first and second
degree networks and ALL networks but never when analysing seeds.
Finally, anti-apoptosis and pain a well-known physiological process
related with neurodegeneration, were also down regulated in the
regenerative model when analysing seeds and networks.
Overall, these results suggested that some common events co-exist
in both models, but others clearly despair allowing the dissection of
mechanisms that defined the endogenous mechanisms of neuropro-
tection versus those that prime to neurodegeneration. The resultant
motive-associated networks were further analysing in order to choice
some key molecules to confirm and help in the interpretation of the
GSEA analysis. The results of apoptosis motive was intriguingly
appearing significative up-regulated in both RA and DA models
www.nature.com/scientificreports
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and being still a matter of controversy in the literature in the RA
model. In the past, we had previously reported the lack of any end-
step of caspase 3-dependent apoptosis11. So, we search for markers in
the network either related to caspase-independent processes such as
the apoptosis-inducing factor (AIF), or to initial steps of apoptosis
such as Cathepsin D (CTSD) (Fig. 2). AIF is normally present in
mitochondria but translocate to the nucleus in caspase-independent
apoptotic-related events12. We found its presence out of the nuclei of
MNs at any condition although an apparent increase in general was
observed in the RA model compared to the DA one (Fig. 2A). Thus
intermediate apoptotic markers can be recruited and mobilized or
altered that indicated somehow that the program is activated but this
that nomeans that the final apoptotic outcome is achieved. Similarly,
CTSD is themajor aspartyl protease of lysosomes that can be released
from them to the cytosol when apoptosis occurs. We observed that it
appeared as a dot-like abundant staining in controls but markedly
reduced in both RA and DA models with no apparent increase in
cytosolic dump inMNs by immunohistochemistry (Fig. 2B). Besides,
we performed immunoblotting analysis to identify the different iso-
forms of CTSD (immature, unprocessed 48-kDa form, vs matured
38-KDa form) and we detected a deficiency in processing after RA
(Fig. 2C). Thus, apoptotic-relatedmarkers were found altered in both
models although this do not implicated the existence of executive
apoptosis.
Furthermore, we wanted to validate also no-significance in GSEA
exploration by studying the expression of necrosis-related maker
present in the network such as the chromatin protein high-mobility
group B1 (HMGB1). If necrosis exists, abundant HMGB1 should be
detected out of the neurons due to membrane bleeding13. But it is
also reported to be abundantly expressed in activated microglia14. By
immunohistochemical analysis we observed that abundant HMGB1
accumulated within and outside neurons, in the spinal cord of RA
animals compared to DA or control samples. However, the analysis
of co-labelling with a widely accepted marker for microglia, Iba1,
revealed that HMGB1 was present within microglia instead of spread
out throughout the parenchyma of extra-neuronal environment
(Fig. 2D). Hence, no necrosis-like phenomenon was observed con-
firming the prediction by GSEA analysis.
We found anoikis, another program of cell death that is also
related to apoptosis to be up-regulated in both models as well.
Anoikis is defined as a death process that is induced by inadequate
or inappropriate cell–matrix interactions15. We chose the b1 subunit
of integrins (Itgb1) as a marker presented in the network and up-
regulated in the proteomic lists. Itgb1 is normally present in the
membrane and we observed this pattern in the DA model (Fig. 3).
In contrast, in the RA model we observed a high content of Itgb1
within the cytoplasm or in a perinuclear staining within the MNs
(Fig. 3). Since, aberrant retention of Itgb1 within the cells can lead to
cell death16 the results pointed to anoikis as a relevant process inMN
degeneration.
On the other hand, in the degenerative process after RA, GSEA
analysis revealed the existence of anti-apoptotic process. To validate
that, we chose Heat shock protein 27 (Hspb1 or Hsp27) as a marker
since it is a chaperone claimed to have major role mediating survival
responses functioning as an antioxidant and inhibiting cell death
pathways to a range of central nervous system insults17. We observed
that Hspb1 was presented spread throughout the processes at the
spinal cord but their levels were higher in RA samples than in DA as
observed by immunohistochemistry (Fig. 4). In contrast, the pattern
of acetylated tubulin to which Hspb1 binds was observed altered
following the opposite profile. Thus in spite of increased expression
of anti-apoptotic markers such as Hspb1, unbalanced ratio of cha-
perone/substrate may not help to effective survival of MNs.
We finally, analysed a marker related to neuropathic pain-assoc-
iated network (Fig. 5). It is generally believed that neuropathic pain is
an expression of neural plasticity, which can occur at several points of
the circuitry including the nociceptive neurons in the dorsal spinal
cord. The Receptor for Activated CKinase 1 (Rack1) is amultifaceted
scaffold protein that interacts with the ribosomal machinery, with
several cell surface receptors and with proteins in the nucleus18. We
analysed Rack1 intracellular localization in the dorsal horn of the
spinal cord were nociceptive neurons are placed by immunohisto-
chemistry. We found that Rack1, normally placed in the nucleus of
the dorsal neurons in control animals markedly changed its subcel-
lular localization to amore diffuse pattern, particularly notably in the
RA model (Fig. 5). The meaning for that change and its implication
Figure 1 | GSEA results of networks related to several molecular processes related to neuronal response to axon damage.Columns indicate the number
of key proteins used as seeds to generate networks. The rest of the columns show the results obtain when comparing DA model vs control (columns
from 2–7), RA vs control (from 8–13) or DA vs RA (from14–20). Direction column indicates whether the motive is up or down regulated regarding
significant differences depending on the p-value when comparing the primary resultant network obtained from seeds (seeds) or that resultant when
including also first degree of interactors (network). Enrichment score (ES) is also indicated.
www.nature.com/scientificreports
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Figure 2 | Network topology and validation for the Apoptotic motive vs Necrotic motive. Top, Nodes represent proteins and edges represent protein-
protein interactions. Green, Purple and Blue seeds belong to the initial motive for which they were previously defined. Dark green edges correspond to
direct interactors (first neighbours) and in light green to the second interactors. Squared frame are seeds also found significantly different altered in the
proteomic results (control vs RA). CTSD and AIFm1 were chosen for further validation in the Apoptotic motive. Bottom panels, (A). representative
microphotographies of L4 spinal cord ventral horn showing localization of AIFm1 (red, alone in left columns) within Nissl labelled MNs (blue, merged
right columns) from either DA or RAmodels or control (Ctrl) animals. Note different abundance but no obvious nuclearization of AIFm1 after RA. (B).
Localization and abundance of CTSD (red, left) within MNs (blue) in control (Ctrl), RA and DA models. (C). Immunoblot of actin and the immature
(48 kDa) or mature (34 kDa) forms of CTSD in the different models and bar graph representing the mean average1/2 SEM of the ratio between two
CTSD isoforms for each condition (* p , 0.05). (D) Necrosis-related marker in the corresponding network, Hmgb1, is abundantly found outside
neurons but co-localizes with microglia (Iba1, green) in both models and contralateral side (Ctl). Scale bar: 20 mm (A) or 50 mm (D).
www.nature.com/scientificreports
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in central sensitization will deserved further analysis as well as other
highlighted molecules for this pain associated-network.
Finally, figure 6 shows the networks associated with anti-anoikis
and selective autophagy motives that were significative for the DA
model. Several proteins highlighted in green were found significantly
altered in the proteomic results compared to controls such as
Pacsin1, also known as syndapin 1, the intermediate filament vimen-
tin and the Calcineurin B homologous protein 1 (Chp1) involved in
vesicle trafficking. Vimentin (Vim) and acidic calponin (Cnn3) were
highly interconnected protein in the network and also highly de-
regulated in the proteomic lists. In contrast in the selective autophagy
network, there was a lack of key proteins significantly altered in the
proteomic lists, although join tendencies revealed the importance of
this network as well.
Discussion
Network-based approaches leverage the idea that complex diseases
can be better understood from a more global perspective by looking
at pre-defined motives instead of individual genes. In this work we
have shown how combining proteomic data with topological
information and posterior computational analyses can help us to
contextualize our findings and may provide new molecular mechan-
isms that rely unexplored. We generated 19 biological processes
comprising the different molecular events involved in retrograde
motoneurodegeneration and neuroprotection after axonal damage
and combined them to an unbiased proteomic dataset for posterior
GSEA analysis. Although some motives were found enriched for
both processes, others were specifically associated with one of them.
Peripheral nerve root avulsion that leads to motoneurodegeneration
is better explained by pain-related molecular events as well as anoi-
kis, apoptosis, anti-apoptosis and rearrangement of cytoskeleton-
related programs. In contrast, the distal axotomy procedure that
engages the endogenous neuroprotective process, although including
also anoikis and apoptosis, is renowned mainly by the presence of
anti-anoikis, ROS hormesis and selective autophagic subroutines.
We focus our discussion on some related nodes that are highlighted
in each of these significative motives and their possible imbrication
to better explain each of these mechanisms. The details of these
ineffective and effective packages for neuroprotection pave the way
Figure 3 | Network topology and validation data for the anoikis motive. Top, Orange and Blue seeds belong to the initial motive for which they were
defined previously either anoikis or pain, respectively. Red edges correspond to direct interactors (first neighbours) and in orange to the second
interactors. Squared frame are seeds also found significantly different modulated in the proteomic results (control vs RA). Bottom panel, representative
mergedmicrophotographies for comparative localization of Itgb1(red) withinMNs (blue nissl) in RA and DAmodels. Differences of itgb1 abundance in
surrounding glia are also pointed (arrowheads). Scale bar: 20 mm.
www.nature.com/scientificreports
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Figure 4 | Network topology and validation data for the anti-apoptosis motive. Top, Green and Purple seeds belong to the initial motive for which they
were defined previously either apoptosis or anti-apoptosis, respectively. Squared frame are seeds also found significantly different modulated in the
proteomic results (control vs RA). Bottom, Immunohistochemical analysis of Hspb1 (red), a chaperone chosen as a target for validation of the motive,
and acetylated alpha tubulin (green), one of their substrates, in the ventral horn of the spinal cord from DA and RA models. Scale bar: 100 mm.
www.nature.com/scientificreports
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Figure 5 | Network topology and validation data for the Painmotive.Top,Orange and Blue seeds belong to the initialmotive for which they were defined
previously either anoikis or pain, respectively. Validation was performed by immunohistochemical analysis of Gnb2/1 (red) in both dorsal neurons
(layers I–III, left panels) or ventral hornMNs (right panels) (blue Nissl) fromDA or RA tissue. Scale bar: 100 mm(left, dorsal horn); 50 mm(right, ventral
horn).
www.nature.com/scientificreports
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for experimentally targeting better therapeutic strategies for future
clinical applications.
Previous attempts to identify and characterize key proteins in
neurodegenerative processes that can be targeted for therapy have
relied heavily on the observation of up- or down-regulation of indi-
vidual candidates to estimate effects on neuronal survival. The idea of
an unbiased search for proteins differently regulated as a result of a
neurodegenerative process is not new, even using the same model of
root avulsion presented here in, but those studies were relied only in
simple microarray analysis19,20. The results from the present proteo-
mic study are more than complementary to transcriptome investi-
gations leading to the fact that protein abundance is affected by both
the synthesis and turnover and generally cannot be predicted merely
from mRNA levels21. Besides, our screen has been performed using
label free quantitative proteomics which has been demonstrated to be
a superior method respect to proteome coverage compared to other
labelled-based approaches. However, quantitative results may not
reflect strictly differences in relative abundance of a single protein
since post-transductional modificationsmay hinder tryptic digestion
and raise quantitative differences in the number of some peptides
affected by thesemodifications yielding qualitative differences. Thus,
although results from GSEA analysis indicated some up or down-
regulation in the motives, since they are based on altered proteins
(either due to abundance or post-translational modifications), attri-
butes in the direction of motives should be considered with precau-
tion. For instance, this was observed for CTSD since by
immunohistochemistry we confirmed the existence of different regu-
lation between DA and RA although the opposite direction of that
predicted by the proteomic analysis. This apparent contradiction
may be due to the observed different processing of the protein in
both models which was less efficient in the RA model. This demon-
strates that different peptide detection of different isoforms of the
same protein can lead to an unspecific read out of up/down regu-
lation. So, the interpretation of the results deserve careful analysis of
an specific protein than merely look for over/down expression as
done in transcriptomic studies. This feature of the dataset forced to
use a more sophisticated computational analysis to search for bio-
logical meaning. The main benefits of analysing phenotypic and
proteomic differences in diseases in a network context is that by
mapping our seeds to an interaction network and searching for
GSEA we are increasing the statistical power of our analyses.
Biological meaning was better achieved through GSEA analysis than
by general GO terms and KEGG pathways analysis commonly used
to get functional enrichment in many other cases. Moreover, includ-
ing in our analyses the direct interactors of our seeds we found
significantly enriched motives not so when analysing seeds alone,
providing new candidate genes potentially associated with ourmodel
or unveiling unknownmechanisms of action. This was the case of the
anti-anoikis motive which was significant only when direct interac-
tors were included in the signature for the DA model. Thus, our
methodological approach shed more accurate mechanistic informa-
tion than any other previously reported transcriptome/proteome
analysis.
Regarding the mechanisms discovered, as expected, those trig-
gered after root avulsion involved pain-related motives. Although
our RA model is not considered a classical model to study neuro-
pathic pain, recently it has been characterized the presence of noci-
ceptive alterations22. Accordingly, we have revealed a particular
network that may help explaining the appearance of central sens-
itization in this model. The network includes several already
described molecules implicated in pain apparition in other models
studied such as dlg4 or PSD-95, NOS1-3, linked to both inflammat-
ory and neuropathic pain, and Grin2a–2b corresponding to NMDA
receptors, NR2A and NR2B, respectively, which overactivation
favours the hyperexcitability of the nociceptive circuit23. Novel rela-
tionship that appears from our analysis is related to pain and
MAPK3, commonly associated to regeneration in the literature24.
We have found in the middle, bridging NMDA and MAPK3, the
protein Grbl/2 or receptor for activated C kinase 1 (RACK1). Several
reports have demonstrated its involvement in multiple biochemical
pathways; however, its implication in pain sensitization has not been
yet connected. RACK1 binds to ribosomes, Src kinases and/or
Figure 6 | Network topology for the anti-anoikis and selective autophagy motives. Yellow and Blue rings are seeds belonging to the initial motive for
which they were defined previously either anti-anoikis or selective autophagy. Light green rounds are proteins form the proteomic list significantly down-
regulated (control vs DA). Squared frames indicated different regulated seeds also found significantly different modulated in the proteomic results.
www.nature.com/scientificreports
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Protein kinase C simultaneously, and it inhibits the Src kinase. It has
been reported that activation of Src-Family Protein Tyrosine Kinases
in the spinal dorsal horn is essential for the initiation and develop-
ment of central sensitization after peripheral tissue and nerve
injury25. Besides, one of its best-characterized substrates is the
NR2B subunit whose phosphorylation triggered downstream signal-
ling transduction26, and causes NR2B receptor-dependent neuronal
plasticity and pain sensitization27. Rack1 is normally located in the
nucleus of the cells and 14-3-3 protein (also named Ywhaq) pro-
motes this translocation28. We found Rack1 misplaced out of the
nucleus in dorsal neurons after damage, observation consistent with
the putative down-regulation of Ywhaq after RA at the proteomic
list. It is plausible that delocalized Rack1 would release Src to be
activated and consequent NMDA increased activity would lead to
hyperexcitability. Although still speculative, the triode form by
Rack1, Src and NMDA seems to be an interesting pathway to take
into consideration for neuropathic pain investigations.
It is intriguing that pain-related networkwas extremely imbricated
within our other networks. For instance, Src appears indeed in the
Anoikis sub-routine presented in bothmodels. Anoikis is a cell death
modality ignited by detachment from the extracellular matrix
(ECM)29, whose resistance has been extensively studied in metastatic
cells. Almost no studies have been found in the neurodegenerative
field in spite of the demonstrated importance of EM attachment for
neurons to survive30. During development, MNs that do not obtain
the correct trophic support due to lack of proper nerve-muscle con-
nections, die by anoikis31 but nobody has studied its relevance in
adult axotomized MNs. Integrins anchored to plasmatic membrane
allow the adhesion to EM and couples to the intracellular actin-
cytoskeleton remodelling through FAK-Src complex, to maintain
cell survival in adhesive cells. Axotomized MNs might suffer from
anoikis and might trigger downstream apoptotic program in both
DA and RA models, although with substantial differences. We
observed Itgb1, the common subunit in all integrin complexes, abun-
dantly accumulated in the interior of the cell instead of being prop-
erly transported to the plasmatic membrane after RA in contrast to
DA. MNs in the DA model might initiate detachment to prepare
themselves for axon prolongation to regenerate while in RA Itgb1 is
futile overexpressed. This might contribute determinately to neur-
onal death. The existence of anoikis in both models although with
very different features is consistent with the engagement of apoptotic
programs.
It has been long reported the observation of apoptotic markers in
avulsed mouse models such as BAX and p5332,33 Using a model of
avulsion of the entire sciatic nerve, a distal lesion similar to DA but
without suture which yield 20% of MN death, Martin et al observed
that BAX and p53 KO mice block that and concluded it was an
apoptotic type of death33. The implication of BAX in the loss of
MNs after root avulsion could not be clarify by using adult BAX-
KO mice32. Besides differences in experimental models which are
relevant to steer MNs toward one or other cell death program, it
should be taken also into consideration that pleiotropic effect of
p53 promote both apoptotic programs (BAX dependent) and inhibi-
tion of anti-anoikis programs mediated by AKT34 (see below). Thus,
from those experiments dual interpretation can be envisaged. From
our work, we concluded that engagement of the anti-anoikis pro-
gram may be the key successful one to boost endogenous neuropro-
tective process after axonal damage. So, the increased MN survival
obtained by blocking p53 can be interpreted by reinforcing anti-
anoikis program even when MN death is not apoptotic. We demon-
strated that none of the models analysed presented degeneration
ended up by apoptosis. This might be thanks to the presence of
concurrent anti-apoptotic subroutines that prevents this in the RA
model. Indeed, inhibitors X-linked Inhibitor of apoptosis proteins
(XIAP) are already higher express in adult versus neonatal MNs and
it seems to be key molecules to render adult MNs more resistant to
axotomy injuries35. We validated this observation analysing the
expression of Hspb1 as an anti-apoptotic molecule36. Hspb1 is a
small multitarget chaperone that binds and influence on the stability
of the tubulins. Mutations in hspb1 leading to excessive chaperone
activity, have been recently found linked to peripheral neuropathy
called Charcot Marie-Tooth disease probably due to microtubule
stabilization37. Balanced stoichiometry between Hspb1 and acety-
lated tubulin is key for correct function of the cytoskeleton preclud-
ing any pro-survival effect38. We found that the ration was inverted
after RA. So again, the overexpression of an anti-apoptotic molecule
does not guarantee the successful recovery form death. The presence
of opposite forces may contribute to slowness of the death process in
RA which is definitely ending lacking apoptotic caspase-dependent
or independent, executive action. This is interesting since we sug-
gested dissociation between triggering or initiating programs and
final outcome that has probably long contribute to the controversy
present around this mechanism of neurodegeneration. AvulsedMNs
will probably finally die due to a combination of detachment, isola-
tion, and anoikis in addition to internal cytoskeletal blocking of the
transport that may difficult resolve properly the programs engaged
either towards apoptosis, that needs proper translocation and energy
supply, or towards anti-apoptosis. Research should be reinforced to
verify whether this corresponds to a new form of death that can be
found in vivo in both acute process and in other chronic diseases
specifically affecting MNs.
Although out of scope of the present manuscript, proteomic ana-
lysis also revealed some particular enzymes involved in amino acid,
fatty acid or citrate cycle metabolism that sign the neurodegenerative
process. Abnormal concentrations of metabolites that reflect axonal
loss or dysfunction have been reported. The most common linked
finding in the literature is a reduced concentration of N-acetyl-aspar-
tate39. Recently, Kachramanoglou and collaborators reported that
increased levels of myo-inositol/creatinine ratio may serve as a mar-
ker of avulsion injury40. However, this parameter seem to diminish
with time cause it might be linked to persistent gliosis. Our present
study proportionate information about other putative metabolites
that can selectively associated with the neurodegenerative avulsion
injury distinguished from a regenerative form. Analysis of this meta-
bolic pathways and deductive subproductsmight be of great value for
clinical outcome measures in trials of repairing strategies.
Regarding the neuroprotective process, what makes successful the
distal axotomymodel. One clue may be related to the choice of other
neuroprotective routes instead of the anti-apoptotic one. In this
regard, we found that anti-anoikis, ROS hormesis and autophagy-
related events seem to be the successful choices. Indeed, recent work
demonstrated that ECM detachment also robustly induces autop-
hagy to presumably protect against this type of stress41. A basal level
of autophagy has been shown to have a neuroprotective role,
although excess autophagy is harmful42,43 and the autophagy of ubi-
quitylated cytosolic proteins is the second mechanism by which ubi-
quitinmay signal protein degradation of selective unwanted proteins
in lysosomes. For instance, Src, which is essential for the anoikis
response as mentioned, can be entrapped and degraded by autopha-
gosomes leading to cell survival44. Selective autophagy can be
engaged to manage ubiquitylated cargo captured by the endosomal
sorting complex for transport (ESCRT) machinery. ESCRT
machinery directly or indirectly, regulates autophagy. By GSEA ana-
lysis we found significative enrichment of components of the ESCRT
complex such as TSg101, putatively down-regulated in the DA
model, and imbricated in the same motive with late-autophagic-
related molecules such as p62/Sqstm1, the ubiquitin-binding pro-
tein45. Thus, these observations suggested that proper running of
the ESCRT machinery and autophagy course might be key elements
in promoting survival after axonal injury.
Finally, several of the proteins we related to both the anti-anoikis
motive and the membrane fusion events were found down-regulated
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in the DA model such as Pacsin 1, scamp1, a secretory carrier mem-
brane protein, NSF, Dlg4 and chp1 (Calcineurin B homologous
protein 1) and SNAP25. All of this proteins are related to vesicle-
mediating transport and endocytic/exocytic membrane traffic often
involved in axonal growth46. These results suggested that proteins
involved in axon tip extensionmight be transported to the lesion site,
within the peripheral nerve and far away from the neuronal soma in
the spinal cord object of our proteomic analysis. Interestingly, the
connections we found between those and phosphatidylinositide 3-
kinase (PI3K) in this network deserves special mention since it
normally increases in both distal axons and cell bodies because
required for both the neurotrophin-induced cell survival and distal
axon growth47. The role of Pi3K-AKT activation as a survival-pro-
moting factor in injured neurons is well documented48 and so we
highlighted here its importance in the anti-anoikis program together
with selective autophagy as key elements for the endogenous neuro-
protective mechanisms.
In conclusion, we have shed some light about the process involved
in retrograde MN reactions to axotomy that are delicate balanced
and can lead to either degeneration or neuroprotection depending on
parameters such as distance of the lesion. The neurodegenerative
process is leading to opposite forces, apoptosis, anoikis and anti-
apoptotic programs, which may contribute to retard the fatal
outcome as well as to give it a characteristic that is not definitely
apoptotic, nor necrotic. Further establishment of themolecular para-
meters that define it may lead to the definition of a new form of
neuronal death, not as pure as those observed in vitro and well
established by the Nomenclature Committee of Cell Death but cer-
tainly present in an in vivo process. At present we do not know the
incidence or implication of this process in other neurodegenerative
processes but we think that this deserves further exploration. On the
other hand, we have dissected out those neuroprotective programs
that can lead to successful recovery after axotomy that include rather
co-running of anti-anoikis and selective autophagy programs. These
are relevant for therapeutical approaches. The unsuccessful
approaches trying to impede the neurodegenerative process, using
anti-apoptotic agents for instance, or any anti-death approach have
been demonstrated to be unsuccessful in trauma or in neurodegen-
erative diseases. So, we show here that the tissue has the capacity to
recover them self and knowing how to do it may be key for therapy
and an alternative way of thinking for therapeutical strategies.
Methods
Models. Sprague–Dawley female rats aged 12 weeks were kept under standard
conditions of light and temperature and fed with food and water ad libitum. We
performed surgical procedures under anesthesia with a cocktail of ketamine/xylazine
0.1 mL/100 gweight i.p essentially as reported previously5. To perform extravertebral
nerve root avulsion of the L4–L5 roots we made a midline skin incision to identify
each side sciatic nerve and applying a moderate traction on selected roots away from
the intervertebral foramina, obtaining the mixed spinal nerves that contained the
motor and sensory roots and dorsal root ganglia out. To produce the distal axotomy
plus suture model, the sciatic nerve was exposed at mid high and freed from
surrounding tissues; then, the nerve was transected and immediately repaired by
fascicular suture (10–0, Ethicon). After both types of lesions, the wound was sutured
by planes, disinfected with povidone iodine and the animals allowed recovering in a
warm environment. All procedures involving animals were carried out in accordance
with the guidelines of our institution and experimental protocols were approved by
the Ethics Committee of our institution, and following the European Community
Council Directive 86/609/EEC.
Sample preparation.We anesthetized groups of rats (n5 4–5) with root avulsion or
distal axotomy and un-operated controls at 7 dpo to obtain L4–L5 spinal cord
segments (5-mm length) samples to be snap-frozen into liquid nitrogen. We
homogenized the tissue in lysis buffer (Hepes 20 mM, Sucrose 250 mM, EDTA
1 mM, EGTA 1 mM and a cocktail of protease and phosphatase inhibitors) with
potter homogenizer on ice. After centrifugation of lysates at 800 3 g for 20 min at
4uC, we collected the supernatant as a cytosolic fraction and quantified by BCA assay
(Pierce Chemical Co.; Rockford, IL, USA). For proteomic analysis, we solubilized
75 mg of each sample in 4% SDS, 8 M Urea, 0.1 M HEPES, 0.1 M DTT and
subsequently reduced, alkylated in 0.05 M iodoacetamide and digested with trypsin
(ratio enzyme:substrate 1510) using the method FASP (Filter Aided Sample
Preparation) as described49. All samples were treated in parallel.
Proteomic analysis. We analysed samples using an LTQ-OrbitrapVelos mass
spectrometer (Thermo Fisher Scientific) coupled to a ProxeonEasyLC (Thermo
Fisher Scientific).We loaded the peptidemixtures directly onto the analytical column
(2 ml?min21) and separated them by reversed-phase chromatography using a 15-cm
column with an inner diameter of 100 mm, packed with 5 mm C18 particles
(NikkyoTechnos Co., Ltd.). Chromatographic gradients started at 97% buffer A (0.1%
formic acid (FA) in water), and 3% buffer B (acetonitrile, 0.1% FA) with a flow rate of
500 nl?min21, and gradually increased to 85% buffer A1 15% buffer B in 4 min, and
to 55% buffer A1 45% buffer B in 120 min. We operated the instrument in TOP20
DDA (Data Dependent Acquisition) mode with one full MS scan in the Orbitrap at a
resolution of 60,000, and amass range ofm/z 350–2,000 followed byMSMS spectra of
the 20 most intense ions. We utilized the Ion Trap by CID (collision induced
dissociation) to produce fragment ion spectra and used normalized collision energy at
35%.We acquired all data with Xcalibur software v2.1.We used ProteomeDiscoverer
software suite (v1.3.0.339, Thermo Fisher Scientific) and the Mascot search engine
(v2.3.01, Matrix Science50) for peptide identification and quantitation. We analysed
the data against SwissProt Rat database (released July 2012) containing the most
common contaminants (599 entries). We used a precursor ion mass tolerance of
7 ppm at the MS1 level and allowed up to three miscleavages for trypsin. The
fragment ion mass tolerance was set to 0.5 Da. Oxidation of methionine and N-
terminal protein acetylation were set as variable modifications whilst cysteine
carbamidomethylation was set as fixed modification. We filtered the peptides based
on their false discovery rate (FDR. 5% not considered). For peptide quantification,
we considered the chromatographic peak of the peptides calculated by Proteome
Discoverer, and median normalized the areas by log2 transformation using R 3.0.2.
We quantified the data using the R packageMSstats (v. 2.0.1)51–53. For each ratio, we
calculated the adjusted p-value54 (p , 0.05 for significance). Finally, we performed
gene ontology and pathway analysis for regulated proteins with STRING55 (http://
string-db.org/) and DAVID Web tools56 (http://david.niaid.nih.gov/david/version2/
index.htm).
Protein-protein interaction networks. Through manual curation of the literature,
we identified the main biological processes (BP) described to be involved in either
regenerative or/and degenerative processes and considering all possible events that
may occur around 7 dpo after injury. By this time, in the RA model there might
happen some problems in autophagy late-events and ER stress canonical response as
we have previously suggested11. Besides, we wanted to determine whether apoptotic,
necrotic or other death-associated pathways such as anoikis31, nucleolar stress57, and
mitochondrial dysfunction58 that has been described in other neurodegenerative
processes, were also present. In addition, we included a pain-related motive since the
apparition of neuropathic pain is markedly relevant after root avulsion59. In
associationwith the theDAmodel, we included a list ofmotives classically involved in
regeneration and some anti-cell death progrmams in order to reveal the endogenous
neuroprotective mechanisms in the promotion of neuronal survival and regeneration
such as anti-anoikis60 or anti-apoptosis and anti-oxidant hormesis61. Subsequently,
we classified all of them into 19 different motives comprised by altogether 331
different genes (that we named seeds) (Table 1, supplementary Table S3). From those
19 different motives, 10 of them accounted for processes related to neuron
regeneration and 9 to neuron degeneration.
For protein interaction data, we collected a subset of all the available Protein-
Protein Interactions (PPIs) from an integrated database containing data from nine
major public PPIs databases: Intact62, MINT63, DIP64, MatrixDB65, InnateDB66,
BioGRID67, BIND68, MPIDB69, and HPRD70, mapping protein identification codes to
Uniprot Accession Codes (Uniprot KB version 2013_01). We collected all experi-
mentally verified direct interactions adding only those described as binary according
to the associated detection methods71. A part from the binary interactome we gen-
erated a second interactome by collecting all experimentally determined interactions
using the ‘spoke expanded’ model in order to transform protein complexes into
binary interactions when the bait of the given affinity purification was specified and
the ‘matrix expanded’ model otherwise72.
From the previousmentioned interactomes, we constructed two types of networks.
First degree networks, which consist of adding the direct interactors of the motive
seeds, and second degree networks by adding an extra level of interactors to the first
degree networks (i.e. also adding direct interactors of the seed interactors). We
assigned a confidence score to each interaction, based on the size and type of
experiment and the number of publications supporting the interaction73,74 and used it
to build high-confidence networks by filtering out those interactions with a nor-
malized confidence score below 0.5.
Gene set enrichment analyses (GSEA). Gene Set Enrichment Analysis is a
computational method that determines whether a predefined list of genes (that we name
‘signatures’) shows significant differences between two biological phenotypes under
study (Subramanian, Tamayo et al. 2005). We performed a GSEA using as signatures
our lists of biological process-associated genes (one for each motive) and our set of
protein-protein interaction networks generated from them. We used GSEA as
implemented in the Bioconductor library phenoTest (R package version 1.9.0) to assess
if the proportion of genes associated with phenotype in each signature is greater than
that outside of the signature. GSEA requires first ranking genes according to their
association with a given phenotype (each neurodegenerative process), and then
determining whether genes included in the signature tend to present either positive or
negative enrichment values. Association with each model was measured using the
previously estimated log2 fold changes obtained from our proteomic analysis. The
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output of the GSEA is an enrichment score (ES), a normalized enrichment score (NES)
which accounts for the size of the gene set being tested, a P-value and an estimated False
discovery rate. Computing NES, P-values and FDR requires a permutation-based
approach for which we computed 10,000 permutations per signature.
Data validation. We used immunohistochemistry and western blot for data
validation. After deeply anesthetized with dolethal we transcardially perfused the
animals with a saline solution containing heparin (10 U/ml), followed by 4%
paraformaldehyde in a 0.1 M phosphate buffer, pH 7.2, for tissue fixation at 7 dpo (n
5 4 at each time post lesion) and removed the L4 and L5 segments (5-mm total
length) of the spinal cord, post-fixed in the same fixative for extra 4 h and
cryopreserved in 30% sucrose overnight. We cut the samples into serial transverse
sections (20-mm thick) onto gelatinized slides using a cryotome (Leica, Heidelberg,
Germany) and preserved them at220uC until used. For immunohistochemistry, we
treated the slides with blocking solution in Tris-buffered saline (TBS) with 0.03%
Triton-X-100 and 10% bovine serum for 1 h and incubated thereafter with different
primary antibodies: Cathepsin D (CTSD), High-Mobility Group Box 1 (HMGB1),
Apoptosis-Inducing Factor, Mitochondrion-Associated, 1 (AIFM1), Guanine
Nucleotide Binding Protein (G Protein), beta Polypeptide 2-Like 1 (GNB2L1,
RACK1), Heat Shock 27 kDa Protein 1 (HSPB1) (Antibodies-online, Aachen,
Germany) overnight at 4uC. After several washes with TBS, 0.05% Tween-20, the
sections were incubated for 2 h with Cy-2 or Cy-3 conjugated donkey anti-rabbit
antibodies (Jackson Immunoresearch,West Grove, PA, USA).We counterstained the
sections with DAPI (Sigma, St Louis, MO, USA), or NeuroTrace Fluorescent Nissl
Stain (Molecular Probes, Leiden, Netherlands) and mounted the slices with
Fluoromount-G mounting medium (SouthernBiotech, Birmingham, AL, USA).
Images of the spinal cord samples from different treatments and controls were taken
under the same exposure time, sensibility, and resolution for each marker analysed,
with the aid of a digital camera (Olympus DP50) attached to the microscope
(Olympus BX51). Confocal microscope examinations were performed with a
Confocal Laser Scanning Microscope (Zeiss LSM 700; Zeiss, Jena, Germany). For
western blotting, we loaded thirty micrograms of cytosolic fractions of L4–L5
segments from each animal model onto 12% SDS-polyacrylamide gels to perform
electrophoretic separation of the proteins following by its transference to a PVDF
membrane in a BioRad cubette system in 25 mM Tris, 192 mM glycine, 20% (v/v)
methanol, pH 8.4. We blocked the membranes with 10% non-fat dry milk in TBS for
1 h at room temperature and then incubated overnight with primary antibody anti
cathepsin D (151000) or anti-actin (Sigma). After several washes, membranes were
incubated for 2 h with an appropriate secondary antibody conjugated with
horseradish peroxidase (153000) (anti-mouse-HRP, Dako Denmark; Glostrup,
Denmark) and anti-rabbit-HRP (Invitrogen Corp.; Carlsbad, CA, USA). The
membrane was visualized using a chemoluminiscent mix 151 [0.5 M luminol,
79.2 mM p-coumaric acid, 1 M Tris-HCl; pH 8.5] and [8.8 M hydrogen peroxide,
1 M Tris-HCl; pH 8.5], and the images analysed with Gene Snap and Gene Tools
softwares, and Gene Genome apparatus (Syngene, Cambridge, UK).
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